A randomized, open-label, comparative, crossover trial on preference, efficacy, and safety profiles of lispro insulin u-100 versus concentrated lispro insulin u-200 in patients with type 2 diabetes mellitus: a possible contribution to greater treatment adherence.
Expert Opin Drug Saf
; 17(5): 445-450, 2018 May.
Article
in En
| MEDLINE
| ID: mdl-29564932
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Diabetes Mellitus, Type 2
/
Medication Adherence
/
Insulin Lispro
/
Hypoglycemic Agents
Type of study:
Clinical_trials
/
Guideline
/
Qualitative_research
Limits:
Aged
/
Female
/
Humans
/
Male
/
Middle aged
Language:
En
Journal:
Expert Opin Drug Saf
Journal subject:
FARMACOLOGIA
/
TERAPIA POR MEDICAMENTOS
Year:
2018
Document type:
Article
Affiliation country:
Italy